Literature DB >> 35907008

Same-day discharge following minimally invasive partial and radical nephrectomy: a National Surgical Quality Improvement Program (NSQIP) analysis.

Krishna Teja Ravivarapu1, Evan Garden1, Chih Peng Chin1, Micah Levy1, Osama Al-Alao1, Joseph Sewell-Araya1, Alexander Small2, Reza Mehrazin1, Michael Palese3.   

Abstract

PURPOSE: Minimally invasive partial nephrectomy (MIPN) and radical nephrectomy (MIRN) have successfully resulted in shorter length of stay (LOS) for patients. Using a national cohort, we compared 30-day outcomes of SDD (LOS = 0) versus standard-length discharge (SLD, LOS = 1-3) for MIRN and MIPN.
METHODS: All patients who underwent MIPN (CPT 50,543) or MIRN (CPT 50,545) in the ACS-NSQIP database from 2012 to 2019 were reviewed. SDD and SLD groups were matched 1:1 by age, sex, race, body mass index, American Society of Anesthesiologists score, and medical comorbidities. We compared baseline characteristics, 30-day Clavien-Dindo (CD) complications, reoperations, and readmissions between SDD and SLD groups. Multivariable logistic regressions were used to evaluate predictors of adverse outcomes.
RESULTS: 28,140 minimally invasive nephrectomy patients were included (SDD n = 237 [0.8%], SLD n = 27,903 [99.2%]). There were no significant differences in 30-day readmissions, CD I/II, CDIII, or CD IV complications before and after matching SDD and SLD groups. On multivariate regression analysis, SDD did not confer increased risk of 30-day complications or readmissions for both MIPN and MIRN.
CONCLUSION: SDD after MIPN and MIRN did not confer increased risk of postoperative complications, reoperation, or readmission compared to SLD. Further research should explore optimal patient selection to ensure safe expansion of this initiative.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Ambulatory surgery; Outpatient surgery; Renal cell carcinoma; Robotic surgery; Surgical outcomes

Year:  2022        PMID: 35907008     DOI: 10.1007/s00345-022-04105-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  11 in total

1.  30-day hospital readmission after robotic partial nephrectomy--are we prepared for Medicare readmission reduction program?

Authors:  Luis Felipe Brandao; Homayoun Zargar; Humberto Laydner; Oktay Akca; Riccardo Autorino; Oliver Ko; Dinesh Samarasekera; Jianbo Li; John Rabets; Jayram Krishnan; Georges-Pascal Haber; Jihad Kaouk; Robert J Stein
Journal:  J Urol       Date:  2014-02-14       Impact factor: 7.450

2.  Early Discharge After Radical Nephrectomy: An Analysis of Complications and Readmissions.

Authors:  Ian Berger; Leilei Xia; Christopher Wirtalla; Thomas J Guzzo; Rachel R Kelz
Journal:  Clin Genitourin Cancer       Date:  2018-12-03       Impact factor: 2.872

3.  Is same-day discharge associated with increased 30-day postoperative complications and readmissions in patients undergoing laparoscopic adrenalectomy?

Authors:  Omair A Shariq; Katherine A Bews; Nicholas P McKenna; Benzon M Dy; Melanie L Lyden; David R Farley; Geoffrey B Thompson; Travis J McKenzie; Elizabeth B Habermann
Journal:  Surgery       Date:  2020-09-30       Impact factor: 3.982

4.  Incidence and risk factors for 30-day readmission in patients undergoing nephrectomy procedures: a contemporary analysis of 5276 cases from the National Surgical Quality Improvement Program database.

Authors:  Riccardo Autorino; Homayoun Zargar; Sam Butler; Humberto Laydner; Jihad H Kaouk
Journal:  Urology       Date:  2015-02-11       Impact factor: 2.649

5.  A 5-Item Frailty Index for Predicting Morbidity and Mortality After Radical Prostatectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database.

Authors:  Mohammed Shahait; Muhieddine Labban; Ryan W Dobbs; Joseph G Cheaib; David I Lee; Hani Tamim; Albert El-Hajj
Journal:  J Endourol       Date:  2021-01-21       Impact factor: 2.942

6.  Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study.

Authors:  Romain Mathieu; Gregory Verhoest; Stéphane Droupy; Alexandre de la Taille; Franck Bruyere; Nicolas Doumerc; Pascal Rischmann; Christophe Vaessen; Morgan Roupret; Karim Bensalah
Journal:  BJU Int       Date:  2013-08       Impact factor: 5.588

Review 7.  Benign prostatic hyperplasia - what do we know?

Authors:  Conor M Devlin; Matthew S Simms; Norman J Maitland
Journal:  BJU Int       Date:  2020-09-24       Impact factor: 5.588

8.  Single-port Robotic Surgery Allows Same-day Discharge in Majority of Cases.

Authors:  Ronney Abaza; Christopher Murphy; Aya Bsatee; David Hugh Brown; Oscar Martinez
Journal:  Urology       Date:  2020-11-17       Impact factor: 2.649

9.  Day-case robotic-assisted partial nephrectomy: feasibility and preliminary results of a prospective evaluation (UroCCR-25 AMBU-REIN study).

Authors:  Jean-Christophe Bernhard; Grégoire Robert; Solène Ricard; Clément Michiels; Grégoire Capon; Astrid Boulenger de Hautecloque; Henri Bensadoun; Joséphine Gay; Julien Rogier; Patrick Tauzin-Fin; Marine Gross-Goupil; Antoine Benard; Karine Nouette; Stéphanie Roullet; Jean-Marie Ferrière
Journal:  World J Urol       Date:  2020-06-08       Impact factor: 4.226

10.  Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.

Authors:  Wojciech Krajewski; Marco Moschini; Joanna Chorbińska; Łukasz Nowak; Sławomir Poletajew; Andrzej Tukiendorf; Luca Afferi; Jeremy Yuen-Chun Teoh; Tim Muilwijk; Steven Joniau; Alessandro Tafuri; Alessandro Antonelli; Francesco Cianflone; Andrea Mari; Ettore Di Trapani; Kees Hendricksen; Mario Alvarez-Maestro; Andrea Rodríguez-Serrano; Giuseppe Simone; Stefania Zamboni; Claudio Simeone; Maria Cristina Marconi; Riccardo Mastroianni; Guillaume Ploussard; Ekaterina Laukhtina; Karl Tully; Anna Kołodziej; Joanna Krajewska; Radosław Piszczek; Evanguelos Xylinas; Romuald Zdrojowy
Journal:  World J Urol       Date:  2020-11-23       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.